59 minutes ago
Zealand Pharma (ZEAL) Shares Plunge 12% Despite Promising Obesity Trial Results
Zealand Pharma (ZEAL) stock plummeted 12% following obesity drug trial results showing impressive weight loss but concerning patient discontinuation rates.
The post Zealand Pharma (ZEAL) Shares Plunge 12% Despite Promising Obesity Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Nu Holdings (NU) Stock Climbs After Rejecting Monzo Acquisition Rumors
- 1 hour ago
Constellation Energy (CEG) Stock Surges on Amazon’s 20-Year Nuclear Power Agreem...
- 1 hour ago
South Korea Proposes Rules to Put Stocks, Bonds and Funds on Blockchain
- 1 hour ago
Intel (INTC) Stock Surges 4% Amid Arizona Foundry Partnership Reports
- 1 hour ago
Liquidia (LQDA) Stock Tumbles 57% Following Patent Infringement Verdict